PRODUCTS

CAS #:

STOCK POSITION

ANTI-CANCER TARGET THERAPY APIS:

BORTEZOMIB

179324-69-7

Stock

DASATINIB

863127-77-9.

Stock

ERLOTINIB

183319-69-9

Stock

GEFITINIB

184475-35-2

Stock

IMATINIB

220127-57-1

Stock

LAPATINIB

388082-78-8

Stock

NILOTINIB

641571-10-0

Stock

SORAFENIB

475207-59-1

Stock

SUNITINB

341031-54-7

Stock

VATALANIB

212141-51-0

Stock

TANDUTINIB

387867-13-2

R&D

CANERTINIB

289499-45-2

R&D

OTHER ONCOLOGY APIS:

IRINOTECAN

136572-09-3

Stock

LENALIDOMIDE

191732-72-6

Stock

PACLITAXEL

33069-62-4

Stock

TOPOTECAN

119413-54-6

Stock

VINBLASTINE

143-67-9

Stock

VINCRISTINE

2068-78-2

Stock

VINFLUNINE

162652-95-1

Stock

VINORELBINE

71486-22-1.

Stock

OTHER APIS:

AMISULPRIDE

71675-85-9.

stock

BETAHISTINE

5579-84-0

stock

DARIFENAXIN

133099-07-7

stock

IVABRADINE

148849-67-6.

stock

MARAVIROC

376348-65-1

stock

NISOLDIPINE

63675-72-9

stock

PALIPERIDONE

144598-75-4

stock

RASAGILINE

161735-79-1

stock

TETRACAINE (HCl)

94-24-6; :136-47-0

Stock

TADALAFIL

171596-29-5

Stock

VARDENAFIL

224785-90-4

Stock